Achieve Life Sciences

Achieve Life Sciences is a specialty pharmaceutical company located in Bothell, Washington, United States. The company is committed to addressing the global smoking health epidemic by developing cytisinicline, a potential new treatment for nicotine dependence, including smoking and vaping. Cytisinicline, derived from natural sources, has shown promise in clinical trials to effectively help smokers quit with minimal side effects.